ALZN就是Junk。。。biotechnology company in the pre-clinical stage,

Alzamend Neuro shares are rising today in response to a positive toxicology report from a mouse study with AL002.

小鼠study，long long away fromhuman study，，

AL002 isn't a drug itself. It's a patented method of withdrawing white blood cells that will mature to become dendritic cells and exposing them to amyloid-beta before reintroducing them into patients. It's supposed to make the immune system extra vigilant about cleaning up amyloid fragments before they can aggregate into plaques associated with AD.天方夜谭，这样的方法在肿瘤try了10几年，never works

 

。。。。。

所有跟帖： 

• 你要等待多久他才能进入临床实验。。1期，2A，2B。 -雨夫子- ♂ (0 bytes) () 07/27/2021 postreply 20:05:58